WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 22, 2006, 26(12):3335-3344; doi:10.1523/JNEUROSCI.5010-05.2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cen, X.
Right arrow Articles by Nabeshima, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cen, X.
Right arrow Articles by Nabeshima, T.

 Previous Article  |  Next Article 

Cellular/Molecular
An Analog of a Dipeptide-Like Structure of FK506 Increases Glial Cell Line-Derived Neurotrophic Factor Expression through cAMP Response Element-Binding Protein Activated by Heat Shock Protein 90/Akt Signaling Pathway

Xiaobo Cen,1,2 * Atsumi Nitta,1 * Shin Ohya,1 Yinglan Zhao,1 Naoya Ozawa,1 Akihiro Mouri,1 Daisuke Ibi,1,7 Li Wang,2 Makiko Suzuki,3 Kuniaki Saito,3 Yasutomo Ito,4 Tetsuya Kawagoe,5 Yukihiro Noda,1,6 Yoshihisa Ito,1,7 Shoei Furukawa,8 and Toshitaka Nabeshima1

1Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan, 2National Chengdu Center for Safety Evaluation of Traditional Chinese Medicine, West China Hospital, Sichuan University, Chengdu 610041, China, 3Department of Laboratory Medicine, Gifu University School of Medicine, Gifu 500-8705, Japan, 4Equipment Center for Research and Education, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan, 5Department of Research and Development, Initium, Tokyo, 107-0062, Japan, 6Division of Clinical Science in Clinical Pharmacy Practice, Management and Research, Faculty of Pharmacy, Meijo University, Nagoya 468-8503, Japan, 7Department of Pharmacology, College of Pharmacy, Nihon University, Funabashi-shi, Chiba 274-8555, Japan, and 8Laboratory of Molecular Biology, Gifu Pharmaceutical University, Gifu 502-8585, Japan

Correspondence should be addressed to Toshitaka Nabeshima, Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Tsuruma-Cho, Showa-ku, Nagoya 466-8560, Japan. Email: tnabeshi{at}med.nagoya-u.ac.jp

Glial cell line-derived neurotrophic factor (GDNF) is an important neurotrophic factor that has therapeutic implications for neurodegenerative disorders. We previously showed that leucine-isoleucine (Leu-Ile), an analog of a dipeptide-like structure of FK506 (tacrolimus), induces GDNF expression both in vivo and in vitro. In this investigation, we sought to clarify the cellular mechanisms underlying the GDNF-inducing effect of this dipeptide. Leu-Ile transport was investigated using fluorescein isothiocyanate-Leu-Ile in cultured neurons, and the results showed the transmembrane mobility of this dipeptide. By liquid chromatography-mass spectrometry and quartz crystal microbalance assay, we identified heat shock cognate protein 70 as a protein binding specifically to Leu-Ile, and molecular modeling showed that the ATPase domain is the predicted binding site. Leu-Ile stimulated Akt phosphorylation, which was attenuated significantly by heat shock protein 90 (Hsp90) inhibitor geldanamycin (GA). Moreover, enhanced interaction between phosphorylated Akt and Hsp90 was detected by immunoprecipitation. Leu-Ile elicited an increase in cAMP response element binding protein (CREB) phosphorylation, which was inhibited by GA, indicating that CREB is a downstream target of Hsp90/Akt signaling. Leu-Ile elevated the levels of GDNF mRNA and protein expression, whereas inhibition of CREB blocked such effects. Leu-Ile promoted the binding activity of phosphorylated CREB with cAMP response element. These findings show that CREB plays a key role in transcriptional regulation of GDNF expression induced by Leu-Ile. In conclusion, Leu-Ile activates Hsp90/Akt/CREB signaling, which contributes to the upregulation of GDNF expression. It may represent a novel lead compound for the treatment of dopaminergic neurons or motoneuron diseases.

Key words: GDNF; dipeptide; FK506; Hsp90; Hsc70; CREB


Received Aug. 6, 2005; revised Feb. 2, 2006; accepted Feb. 2, 2006.

Correspondence should be addressed to Toshitaka Nabeshima, Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Tsuruma-Cho, Showa-ku, Nagoya 466-8560, Japan. Email: tnabeshi{at}med.nagoya-u.ac.jp




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Y. Shin, H. Song, C. G. Kim, Y.-K. Choi, K. S. Lee, S.-J. Lee, H.-J. Lee, Y. Lim, and Y. H. Lee
Egr-1 Is Necessary for Fibroblast Growth Factor-2-induced Transcriptional Activation of the Glial Cell Line-derived Neurotrophic Factor in Murine Astrocytes
J. Biol. Chem., October 30, 2009; 284(44): 30583 - 30593.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-